News Releases - Achieve Life Sciences
HOME
ABOUT ACHIEVE
About Achieve
Management Team
Board of Directors
PRODUCTS
Cytisinicline
NEWS
Press Releases
Events
Blog
INVESTORS
CONTACT
HOME
ABOUT ACHIEVE
About Achieve
Senior Management
PRODUCTS
Cytisinicline
NEWS
INVESTORS
CONTACT
News Releases
Home
/
News Releases
Home
ivps4
2017-06-16T21:39:52+00:00
Investors Home
Corporate Governance
News Releases
Financial Information
SEC Filings
Events and Webcasts
Investor Contacts
Investor Alerts
NASDAQ: ACHV
NASDAQ: OGXI
News Releases
Investor Alerts
Year
All Years
2021
2020
2019
2018
2017
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Jun 29, 2020
Achieve Life Sciences Announces Pricing of $6 Million Registered Direct Offering
Jun 29, 2020
Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) as a Treatment to Quit Smoking
May 14, 2020
Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program
May 5, 2020
Achieve Life Sciences to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 14, 2020
Apr 30, 2020
Achieve Life Sciences Announces Private Placement of $1.9 Million
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
…
20
»
NASDAQ: ACHV
NASDAQ: OGXI
1dy
1mo
6mo
1yr
5yr
Stock Info
NASDAQ: ACHV
NASDAQ: OGXI
Go to Top
